Epitome Therapeutics
Epitome Therapeutics is an Industry & Hardware startup based in Vienna, Austria, most recent round Seed, 1 tracked investor.
About Epitome Therapeutics
Epitome Therapeutics is a startup founded in 2025 based in Vienna, Austria. Its most recent tracked round is Seed. Brouky classifies it under Industry & Hardware. Brouky records 1 investor associated with the company.
Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a proprietary epigenome editing platform that enables precise, durable, and tunable control of gene expression without altering DNA sequences, targeting diseases driven by dysregulated gene activity such as rare and metabolic disorders.
Explore Epitome Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.